these results support the use of L-tryptophan as an augmentation strategy in treatment-resistant depression, bringing about symptom improvement in 56% of the sample. This compares favourably to the published 50-60% response rate with lithium augmentation.
1
BJPsych Bulletin | Cambridge Core
